Evidence map›Paper›PMID 35386579›Full record

ArticleRespirology case reports2022

COVID-19 vaccine-associated organizing pneumonia.

Tomohiro Yoshikawa, Katsuyoshi Tomomatsu, Eriko Okazaki, Tomoe Takeuchi, Yukihiro Horio, Yusuke Kondo, Tsuyoshi Oguma, Koichiro Asano

Open access · goldAbstract readCase Reports
In one paragraph

Article in Respirology case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Observational
  4. Article
  5. Article
  6. Hypereosinophilia after vaccination with the SARS-CoV-2 mRNA vaccines.The journal of allergy and clinical immunology. In practice · 2023
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Tomohiro YoshikawaDivision of Pulmonary Medicine, Department of Medicine Tokai University School of Medicine Isehara Japan.
Katsuyoshi TomomatsuDivision of Pulmonary Medicine, Department of Medicine Tokai University School of Medicine Isehara Japan.ORCID https://orcid.org/0000-0002-0506-0323
Eriko OkazakiDivision of Pulmonary Medicine, Department of Medicine Tokai University School of Medicine Isehara Japan.
Tomoe TakeuchiDivision of Pulmonary Medicine, Department of Medicine Tokai University School of Medicine Isehara Japan.
Yukihiro HorioDivision of Pulmonary Medicine, Department of Medicine Tokai University School of Medicine Isehara Japan.
Yusuke KondoDepartment of Pathology Tokai University School of Medicine Isehara Japan.
Tsuyoshi OgumaDivision of Pulmonary Medicine, Department of Medicine Tokai University School of Medicine Isehara Japan.
Koichiro AsanoDivision of Pulmonary Medicine, Department of Medicine Tokai University School of Medicine Isehara Japan.ORCID https://orcid.org/0000-0002-9044-3061
Tokai University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the first case of organizing pneumonia (OP) associated with a new coronavirus disease (COVID-19) vaccination. A 78-year-old woman developed cough and dyspnoea 10 days after receiving BNT162b2. Chest computed tomography (CT) revealed consolidation in the bilateral lower lobes of the lungs. Although antibiotic treatment did not improve her symptoms, she received a second vaccination as scheduled. She was referred to our hospital because of worsening dyspnoea on day 9 after the second vaccination, with reversed halo signs in the bilateral lower pulmonary lobes and new consolidation in the left lingual region on chest CT on day 15. She was diagnosed with OP based on bronchoalveolar lavage and transbronchial lung biopsy findings. Treatment with oral prednisolone 0.5 mg/kg/day immediately improved the symptoms and chest imaging findings. In the absence of other triggering factors, we considered this case as being COVID-19 vaccine-associated following the first and second vaccinations.

Indexed as

adverse eventsCOVID‐19interstitial lung diseaseorganizing pneumoniavaccine

Identifiers

PMID35386579
PMCPMC8965045
OpenAlexW4220851210

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.